DNA Methylation and Target Gene Expression in Fatty Liver Progression From Simple Steatosis to Advanced Fibrosis
Liver International · 2025
DOI: 10.1111/liv.70040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, 2025. Verfasst von Jin Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: DNA Methylation, Non-alcoholic Fatty Liver Disease, Liver Cirrhosis, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
Background and Aim Metabolic dysfunction‐associated steatotic liver diseases (MASLD), also known as non‐alcoholic fatty liver diseases (NAFLD), have become a leading risk factor for hepatocellular carcinoma (HCC) in Western countries. NAFLD progresses from simple steatosis to HCC, with advanced liver fibrosis (ALF) and metabolic dysfunction‐associated steatohepatitis (MASH) or non‐alcoholic steatohepatitis (NASH) representing the two preceding high‐risk stages.
Methods
We analysed changes in the DNA methylation landscape from simple steatosis to ALF or NASH and determined their relevance in gene regulation and HCC survival. Methylomic datasets generated from applying the Illumina 450K BeadChip on human MASLD/NAFLD liver samples were analysed using integrative data analyses to identify differentially methylated regions (DMRs) associated with ALF (F3/4 vs. F0/1) or non‐fibrotic NASH (NASH‐F0/1 vs. NAFLD‐F0/1).
Results
Gene Set Enrichment Analysis (GSEA) of genes associated with fibrosis‐DMRs showed enrichment in xenobiotic metabolism, UV response and hypoxia pathways. Expression of 25 DMR‐associated genes showed significant associations with HCC survival outcomes, including 16 genes with fibrosis‐DMRs and 2 with NASH‐DMRs mapped to their promoter regions. Binding motifs of seven transcription factors (TFs) were enriched in fibrosis‐DMRs. Four DMR‐associated genes (ESR1, TYW3, CLGN and TUBB) displayed an inverse relationship between promoter methylation and gene expression during human MASLD progression, which was further validated in a mouse MASLD model.
Conclusions
We propose a model in which changes in promoter DNA methylation during NAFLD progression regulate gene expression, impacting HCC survival outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Biosciences and Technology, Texas A&M University Health Science Center, Houston, Texas, USA.
- Department of Translational Medical Sciences, School of Medicine, Texas A&M University Health Science Center, Houston, Texas, USA.
- Department of Epidemiology, School of Public Health, The University of Texas Health Science Center at Houston, Brownsville, Texas, USA.
ORCID-Profile: Robert Y L Tsai
Förderung
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Li, J., Liu, X., Tran, T. T., Lee, M., & Tsai, R. Y. L. (2025). DNA Methylation and Target Gene Expression in Fatty Liver Progression From Simple Steatosis to Advanced Fibrosis. Liver International. https://doi.org/10.1111/liv.70040
Vancouver
Li J, Liu X, Tran TT, Lee M, Tsai RYL. DNA Methylation and Target Gene Expression in Fatty Liver Progression From Simple Steatosis to Advanced Fibrosis. Liver International. 2025. doi:10.1111/liv.70040
BibTeX
@article{Li2025,
author = {Li, Jin and Liu, Xiaoqin and Tran, Tran T and Lee, Miryoung and Tsai, Robert Y L},
title = {DNA Methylation and Target Gene Expression in Fatty Liver Progression From Simple Steatosis to Advanced Fibrosis},
journal = {Liver International},
year = {2025},
doi = {10.1111/liv.70040}
}
EUVIMED